Research Disclaimer
This article reviews published scientific literature for educational purposes only. All compounds referenced are sold by Blank Peptides exclusively for in-vitro research and laboratory use. Nothing in this article constitutes medical advice, a treatment recommendation, or an endorsement of human use.
The research peptide landscape in 2026 is broader than it’s ever been. What used to be a handful of compounds studied in niche labs has expanded into a multi-category field spanning metabolic research, tissue repair, neuroprotection, immune modulation, and longevity science.
The challenge isn’t finding peptides to study — it’s knowing which ones have real data behind them versus which ones are riding the hype cycle. This guide organizes the most well-characterized research peptides by category, with an emphasis on published evidence and mechanistic clarity.
Growth Hormone Secretagogues
GH secretagogues remain the most commercially popular category of research peptides, and the published literature here is extensive.
Ipamorelin
A selective GH-releasing peptide that stimulates GH secretion through ghrelin receptor agonism without significantly elevating cortisol or prolactin. Published data in European Journal of Endocrinology established its selectivity profile, making it a preferred tool for studying GH release in isolation from other pituitary hormones.
Sermorelin (GRF 1-29)
The truncated GHRH fragment that pioneered the secretagogue category. Its short half-life is a limitation but also a feature for researchers who want to study acute GH pulse dynamics. Published clinical data from the 1990s through 2000s in Journal of Clinical Endocrinology & Metabolism remains foundational.
CJC-1295
Available in two forms with distinct pharmacokinetic profiles:
- With DAC (Drug Affinity Complex) — binds albumin, extends half-life to ~6–8 days, produces sustained GH elevation
- Without DAC (Modified GRF 1-29) — shorter, more pulsatile GH release pattern
Published pharmacokinetic data in Journal of Clinical Endocrinology & Metabolism documented sustained IGF-1 elevation with the DAC variant.
Tesamorelin
The only GH secretagogue with FDA approval (for HIV-associated lipodystrophy). Full-length GHRH(1-44) with a hexenoic acid modification.
Tissue Repair and Recovery
This category has seen enormous research interest, driven largely by two peptides with unusually robust preclinical datasets.
BPC-157
Body Protection Compound-157, a 15-amino acid gastric peptide fragment with over 100 published studies documenting tissue-protective and regenerative effects. Published data spans:
- Gastric mucosal healing
- Tendon and ligament repair
- Nerve regeneration in animal models
- Growth factor upregulation (VEGF, EGF, nitric oxide pathways)
Human clinical trial data remains limited.
TB-500
A 43-amino acid synthetic fragment of Thymosin Beta-4 that promotes cell migration and angiogenesis through interaction with G-actin. Published research in Annals of the New York Academy of Sciences documented its role in wound repair and cardiac tissue regeneration.
GHK-Cu
A copper-binding tripeptide that occurs naturally in human plasma and declines with age. Published data in Journal of Biological Chemistry and Journal of Investigative Dermatology documented roles in:
- Collagen synthesis
- Wound healing acceleration
- Anti-inflammatory signaling
Its dual function as both a signaling peptide and a copper delivery vehicle makes it mechanistically distinct from other repair peptides.
Metabolic and Weight Research
The GLP-1 receptor agonist revolution has put metabolic peptides at the center of biomedical research.
Semaglutide
A GLP-1 receptor agonist with the most extensive published dataset in the metabolic peptide space. The STEP trial series in the New England Journal of Medicine documented significant effects on body weight and metabolic markers. The albumin-binding C-18 fatty acid modification gives it a half-life of ~7 days.
Tirzepatide
A dual GIP/GLP-1 receptor agonist. The SURMOUNT trials published in the NEJM documented weight reduction outcomes that exceeded single-agonist approaches in head-to-head comparisons, establishing dual-agonist signaling as a distinct pharmacological strategy.
Retatrutide
A triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously.
Anti-Inflammatory and Immune Modulation
KPV
The C-terminal tripeptide of alpha-MSH (Lys-Pro-Val) that retains anti-inflammatory activity without melanogenic effects. Published data in Journal of Biological Chemistry and PNAS documented:
- NF-κB pathway inhibition
- Reduced pro-inflammatory cytokine expression
- Particularly promising results in intestinal inflammation models
Glutathione
The body’s most abundant endogenous antioxidant, a tripeptide (Glu-Cys-Gly) critical for redox homeostasis. Published research in Free Radical Biology and Medicine links GSH depletion to oxidative stress in virtually every organ system. Its role extends beyond antioxidant activity to include:
- Immune cell function
- Detoxification pathways
- Mitochondrial protection
Longevity and Mitochondrial Research
Epithalon
A synthetic tetrapeptide analog of Epithalamin that acts on telomerase activity. Published data by Khavinson et al. in Bulletin of Experimental Biology and Medicine documented telomere elongation in human cell cultures and increased telomerase expression. Epithalon occupies a unique niche as one of the few peptides with published telomere-specific data.
MOTS-c
A mitochondria-derived peptide encoded within the 12S rRNA gene. Published data in Cell Metabolism (2015) documented its role in regulating metabolic homeostasis through AMPK activation. Subsequent research has linked MOTS-c to:
- Exercise-mimetic effects
- Improved insulin sensitivity
- A unique biological origin — mitochondrial-encoded rather than nuclear-encoded
NAD+
While technically a dinucleotide rather than a peptide, NAD+ is a cornerstone of cellular energy metabolism and sirtuin activation. Published research in Cell and Science has documented age-related NAD+ decline and the downstream consequences for mitochondrial function, DNA repair, and inflammatory signaling.
Melanocortin Peptides
Melanotan II
A cyclic heptapeptide analog of alpha-MSH that acts as a non-selective melanocortin receptor agonist (MC1R through MC5R). Published data in Peptides and Life Sciences documented its melanogenic activity and additional melanocortin-mediated effects. Its non-selective receptor profile makes it versatile but also necessitates careful experimental design to isolate receptor-specific effects.
What Separates Good Research Peptides from Bad Ones
Purity matters more than price. Reputable suppliers provide third-party HPLC and mass spectrometry certificates of analysis for every batch. Published research consistently notes that peptide impurities can introduce confounding variables that invalidate experimental results.
A 99%+ purity standard isn’t a marketing claim — it’s a basic requirement for producing reliable data. Beyond purity, researchers should verify:
- Proper lyophilization and storage conditions
- Batch-to-batch consistency from their supplier
- Third-party COA verification for every compound
The difference between publishable results and wasted time often starts at the reagent level.
Browse These Compounds